XML 39 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Summary of Significant Accounting Policies - Potentially Dilutive Securities Excluded from Calculation of Diluted Net Loss per Share Due to Anti-Dilutive Effect (Detail) - shares
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2012
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share 7,859 8,001 7,859 8,001  
Options to Purchase Common Stock, Including Purchases from Contributions to ESPP [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share 7,227 7,404 7,227 7,404  
Restricted Stock Units (RSUs) [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share 599 432 599 432  
Restricted Stock Awards [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share 33 15 33 15  
Warrants to Purchase Common Stock [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive securities excluded from computation of earnings per share   150 [1]   150 [1] 150,000
[1] In 2012, the Company issued a warrant with a ten-year term to purchase 150,000 shares of its common stock at an exercise price of $20.00 per share. The warrant was exercised in January 2022.